Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Sameer Nakhle"'
Publikováno v:
Journal of the Endocrine Society. 6:A326-A326
Background Metformin is the first line of treatment for patients with Diabetes Mellitus type 2. Despite multiple benefits, metformin is contraindicated in stage 4 renal disease due to an increased risk of metformin associated lactic acidosis (MALA).